File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1007/s10637-015-0313-8
- Scopus: eid_2-s2.0-84959151856
- WOS: WOS:000368725100011
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: A phase I trial of ANG1/2-Tie2 inhibitor trebaninib (AMG386) and temsirolimus in advanced solid tumors (PJC008/NCI♯9041)
| Title | A phase I trial of ANG1/2-Tie2 inhibitor trebaninib (AMG386) and temsirolimus in advanced solid tumors (PJC008/NCI♯9041) |
|---|---|
| Authors | |
| Keywords | AMG386 Combination therapy Phase 1 Temsirolimus Trebananib |
| Issue Date | 2016 |
| Publisher | Springer New York LLC. The Journal's web site is located at http://springerlink.metapress.com/openurl.asp?genre=journal&issn=0167-6997 |
| Citation | Investigational New Drugs, 2016, v. 34 n. 1, p. 104-111 How to Cite? |
| Persistent Identifier | http://hdl.handle.net/10722/234690 |
| ISSN | 2021 Impact Factor: 3.651 2020 SCImago Journal Rankings: 1.254 |
| PubMed Central ID | |
| ISI Accession Number ID |
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Chiu, WYJ | - |
| dc.contributor.author | Hotte, SJ | - |
| dc.contributor.author | Kollmannsberger, CK | - |
| dc.contributor.author | Renouf, DJ | - |
| dc.contributor.author | Cescon, DW | - |
| dc.contributor.author | Hedley, D | - |
| dc.contributor.author | Chow, S | - |
| dc.contributor.author | Moscow, J | - |
| dc.contributor.author | Perry, M | - |
| dc.contributor.author | Diaz-Padilla, I | - |
| dc.contributor.author | Tan, D | - |
| dc.contributor.author | Hirte, H | - |
| dc.contributor.author | McWhirter, E | - |
| dc.contributor.author | Chen, H | - |
| dc.contributor.author | Siu, LL | - |
| dc.contributor.author | Bedard, PL | - |
| dc.date.accessioned | 2016-10-14T13:48:38Z | - |
| dc.date.available | 2016-10-14T13:48:38Z | - |
| dc.date.issued | 2016 | - |
| dc.identifier.citation | Investigational New Drugs, 2016, v. 34 n. 1, p. 104-111 | - |
| dc.identifier.issn | 0167-6997 | - |
| dc.identifier.uri | http://hdl.handle.net/10722/234690 | - |
| dc.language | eng | - |
| dc.publisher | Springer New York LLC. The Journal's web site is located at http://springerlink.metapress.com/openurl.asp?genre=journal&issn=0167-6997 | - |
| dc.relation.ispartof | Investigational New Drugs | - |
| dc.rights | The final publication is available at Springer via http://dx.doi.org/[insert DOI] | - |
| dc.subject | AMG386 | - |
| dc.subject | Combination therapy | - |
| dc.subject | Phase 1 | - |
| dc.subject | Temsirolimus | - |
| dc.subject | Trebananib | - |
| dc.title | A phase I trial of ANG1/2-Tie2 inhibitor trebaninib (AMG386) and temsirolimus in advanced solid tumors (PJC008/NCI♯9041) | - |
| dc.type | Article | - |
| dc.identifier.email | Chiu, WYJ: jwychiu@hku.hk | - |
| dc.identifier.authority | Chiu, WYJ=rp01917 | - |
| dc.identifier.doi | 10.1007/s10637-015-0313-8 | - |
| dc.identifier.pmcid | PMC4718956 | - |
| dc.identifier.scopus | eid_2-s2.0-84959151856 | - |
| dc.identifier.hkuros | 267915 | - |
| dc.identifier.volume | 34 | - |
| dc.identifier.issue | 1 | - |
| dc.identifier.spage | 104 | - |
| dc.identifier.epage | 111 | - |
| dc.identifier.isi | WOS:000368725100011 | - |
| dc.publisher.place | United States | - |
| dc.identifier.issnl | 0167-6997 | - |